Nuveen Mid Cap Value Retire holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Nuveen Mid Cap Value Fund Retirement Class TRVRX
- NAV / 1-Day Return 20.89 / +1.90 %
- Total Assets 1.7B
-
Adj. Expense Ratio
0.710%
- Expense Ratio 0.710%
- Distribution Fee Level Below Average
- Share Class Type Retirement, Large
- Category Mid-Cap Value
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 1.33%
- Turnover 28%
USD | NAV as of Jun 12, 2026 | 1-Day Return as of Jun 12, 2026, 12:27 AM GMT+0
Morningstar’s Analysis TRVRX
Will TRVRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the TRVRX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of TRVRX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
TD Synnex Corp | 2.98 | 50M | Technology |
Ciena Corp | 2.48 | 41M | Technology |
WESCO International Inc | 2.32 | 39M | Industrials |
Permian Resources Corp Class A | 2.13 | 36M | Energy |
Williams Companies Inc | 2.09 | 35M | Energy |
MKS Inc | 2.07 | 34M | Technology |
Dover Corp | 2.07 | 34M | Industrials |
Digital Realty Trust Inc | 2.06 | 34M | Real Estate |
Allstate Corp | 2.04 | 34M | Financial Services |
Jazz Pharmaceuticals PLC | 2.03 | 34M | Healthcare |
United States